CX3CL1 and neoplasm: For this reason, an increase in CX3CL1 expression in the tumor improves the prognosis for patients with breast carcinoma [74], colorectal cancer [71,79], gastric adenocarcinoma [73], glioma [78], lung adenocarcinoma [80] and soft tissue sarcomas [81].